Neuropace, Inc. Common Stock NPCE
$7.56
-37.10%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (4 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $15.67
- Implied Upside
- +107.2%
- Price Target Range
- $7.00 – $22.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-13 | JP MorganRohin Patel |
Downgrades | Overweight → Neutral | $20 → $9 |
| 2026-11-13 | KeybancBrett Fishbin |
Maintains | Overweight | $18 → $14 |
| 2026-11-13 | Leerink PartnersMike Kratky |
Downgrades | Outperform → Market perform | $7 |
| 2026-09-18 | KeybancBrett Fishbin |
Initiates coverage on | Overweight | $18 |
| 2026-07-29 | HC Wainwright & Co.Yi Chen |
Reiterates | Buy | $20 |
| 2026-07-23 | MizuhoAnthony Petrone |
Initiates coverage on | Outperform | $22 |
| 2026-05-15 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $19 → $20 |
| 2026-01-27 | HC Wainwright & Co.Yi Chen |
Maintains | Buy | $18 → $19 |
| 2025-12-16 | UBSPriya Sachdeva |
Maintains | Buy | $18 → $22 |
| 2025-12-10 | JP MorganRohin Patel |
Maintains | Overweight | $18 → $20 |
| 2025-11-05 | JP MorganRohin Patel |
Maintains | Overweight | $16 → $18 |
| 2025-11-05 | Wells FargoVik Chopra |
Maintains | Overweight | $15 → $16 |
| 2025-08-13 | Wells FargoVik Chopra |
Maintains | Overweight | $17 → $15 |
| 2025-05-28 | HC Wainwright & Co.Yi Chen |
Initiates coverage on | Buy | $18 |
| 2025-05-14 | JP MorganRobbie Marcus |
Maintains | Overweight | $14 → $16 |
| 2025-05-14 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $17 |
| 2025-03-05 | Cantor FitzgeraldRoss Osborn |
Maintains | Overweight | $19 → $20 |
| 2025-01-30 | Wells FargoLarry Biegelsen |
Maintains | Overweight | $13 → $17 |
| 2025-01-21 | UBSPriya Sachdeva |
Initiates coverage on | Buy | $17 |
| 2024-12-17 | JP MorganRobbie Marcus |
Maintains | Overweight | $9 → $14 |
| 2024-11-13 | Wells FargoVik Chopra |
Maintains | Overweight | $15 → $13 |
| 2024-08-14 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $18 |
| 2024-08-14 | Wells FargoVik Chopra |
Maintains | Overweight | $20 → $15 |
| 2024-07-15 | Morgan StanleyDrew Ranieri |
Maintains | Equal-weight | $10 → $8 |
| 2024-05-09 | Cantor FitzgeraldRoss Osborn |
Reiterates | Overweight | $18 |
| 2024-03-14 | Wells FargoLawrence Biegelsen |
Upgrades | Equal-weight → Overweight | $16 → $20 |
| 2024-03-12 | JP MorganRobbie Marcus |
Maintains | Overweight | $9 → $17 |
| 2024-03-06 | Cantor FitzgeraldRoss Osborn |
Maintains | Overweight | $16 → $18 |
| 2024-03-06 | Morgan StanleyDrew Ranieri |
Maintains | Equal-weight | $9 → $13 |
| 2024-02-22 | Wells FargoLawrence Biegelsen |
Maintains | Equal-weight | $9 → $16 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $7.56
- Market Cap
- $412.58 million
- 52-Week Range
- $5.46 – $19.60
- Average Volume
- 318K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.